Anny Fortin, Ph.D. - Publications

Affiliations: 
2003 McGill University, Montreal, QC, Canada 
Area:
Genetics

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Moradin N, Torre S, Gauthier S, Tam M, Hawari J, Vandercruyssen K, De Spiegeleer B, Fortin A, Stevenson MM, Gros P. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria. Malaria Journal. 15: 260. PMID 27150250 DOI: 10.1186/s12936-016-1317-3  0.48
2015 Sonzogni-Desautels K, Renteria AE, Camargo FV, Di Lenardo TZ, Mikhail A, Arrowood MJ, Fortin A, Ndao M. Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice. Frontiers in Microbiology. 6: 973. PMID 26441906 DOI: 10.3389/fmicb.2015.00973  0.48
2015 Paulussen C, Boulet G, Bosschaerts T, Cos P, Fortin A, Maes L. Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis Mycoses. 58: 127-132. DOI: 10.1111/myc.12286  0.48
2014 Logie C, Dimaras H, Fortin A, Ramón-García S. Challenges faced by multidisplinary new investigators on addressing grand challenges in global health Globalization and Health. 10. PMID 24735677 DOI: 10.1186/1744-8603-10-27  0.48
2014 Shio MT, Paquet M, Martel C, Bosschaerts T, Stienstra S, Olivier M, Fortin A. Drug delivery by tattooing to treat cutaneous leishmaniasis. Scientific Reports. 4: 4156. PMID 24561704 DOI: 10.1038/srep04156  0.48
2014 Hernández L, Gálvez R, Montoya A, Checa R, Bello A, Bosschaerts T, Jansen H, Rupérez C, Fortin A, Miró G. First study on efficacy and tolerability of a new alkylphosphocholine molecule (oleylphosphocholine - OlPC) in the treatment of canine leishmaniosis due to Leishmania infantum Parasitology Research. 113: 157-164. PMID 24192865 DOI: 10.1007/s00436-013-3638-2  0.48
2014 Fortin A, Caridha DP, Leed S, Ngundam F, Sena J, Bosschaerts T, Parriott S, Hickman MR, Hudson TH, Grogl M. Direct Comparison of the Efficacy and Safety of Oral Treatments with Oleylphosphocholine (OlPC) and Miltefosine in a Mouse Model of L. major Cutaneous Leishmaniasis Plos Neglected Tropical Diseases. 8. DOI: 10.1371/journal.pntd.0003144  0.48
2012 Wiltshire SA, Diez E, Miao Q, Dubé MP, Gagné M, Paquette O, Lafrenière RG, Ndao M, Castellani LW, Skamene E, Vidal SM, Fortin A. Genetic control of high density lipoprotein-cholesterol in AcB/BcA recombinant congenic strains of mice. Physiological Genomics. 44: 843-52. PMID 22805347 DOI: 10.1152/physiolgenomics.00025.2012  0.48
2012 Fortin A, Hendrickx S, Yardley V, Cos P, Jansen H, Maes L. Efficacy and tolerability of oleylphosphocholine (OLPC) in a laboratory model of visceral leishmaniasis Journal of Antimicrobial Chemotherapy. 67: 2707-2712. PMID 22782488 DOI: 10.1093/jac/dks273  0.48
2011 Ramirez-Aquino R, Radovanovic I, Fortin A, Sciutto-Conde E, Fragoso-González G, Gros P, Aguilar-Delfin I. Identification of loci controlling restriction of parasite growth in experimental Taenia crassiceps cysticercosis. Plos Neglected Tropical Diseases. 5: e1435. PMID 22206032 DOI: 10.1371/journal.pntd.0001435  0.48
2011 Mogil JS, Sorge RE, LaCroix-Fralish ML, Smith SB, Fortin A, Sotocinal SG, Ritchie J, Austin JS, Schorscher-Petcu A, Melmed K, Czerminski J, Bittong RA, Mokris JB, Neubert JK, Campbell CM, et al. Pain sensitivity and vasopressin analgesia are mediated by a gene-sex-environment interaction. Nature Neuroscience. 14: 1569-73. PMID 22019732 DOI: 10.1038/nn.2941  0.48
2011 Fortin A, Jansen FH. ACTs for the treatment of schistosomiasis. The Lancet. Infectious Diseases. 11: 498. PMID 21700239 DOI: 10.1016/S1473-3099(11)70157-8  0.48
2011 Hambleton S, Salem S, Bustamante J, Bigley V, Boisson-Dupuis S, Azevedo J, Fortin A, Haniffa M, Ceron-Gutierrez L, Bacon CM, Menon G, Trouillet C, McDonald D, Carey P, Ginhoux F, et al. IRF8 mutations and human dendritic-cell immunodeficiency. The New England Journal of Medicine. 365: 127-38. PMID 21524210 DOI: 10.1056/NEJMoa1100066  0.48
2011 Longley R, Smith C, Fortin A, Berghout J, McMorran B, Burgio G, Foote S, Gros P. Host resistance to malaria: using mouse models to explore the host response. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 22: 32-42. PMID 21116636 DOI: 10.1007/s00335-010-9302-6  0.48
2011 Fortin A, Verbeeck RK, Jansen FH. Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers. European Journal of Clinical Pharmacology. 67: 267-75. PMID 20949263 DOI: 10.1007/s00228-010-0911-5  0.48
2010 Fortin A, Diez E, Ritchie J, Sotocinal SG, Dube MP, Gagne M, Paquette O, Skamene E, Mogil JS. Positional cloning of a quantitative trait locus contributing to pain sensitivity: possible mediation by Tyrp1. Genes, Brain, and Behavior. 9: 856-67. PMID 20633051 DOI: 10.1111/j.1601-183X.2010.00618.x  0.48
2010 Min-Oo G, Fortin A, Poulin JF, Gros P. Cysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin. Antimicrobial Agents and Chemotherapy. 54: 3262-70. PMID 20479197 DOI: 10.1128/AAC.01719-09  0.48
2010 Stevenson MM, Gros P, Olivier M, Fortin A, Serghides L. Cerebral malaria: human versus mouse studies. Trends in Parasitology. 26: 274-5. PMID 20382077 DOI: 10.1016/j.pt.2010.03.008  0.48
2010 Min-Oo G, Ayi K, Bongfen SE, Tam M, Radovanovic I, Gauthier S, Santiago H, Rothfuchs AG, Roffê E, Sher A, Mullick A, Fortin A, Stevenson MM, Kain KC, Gros P. Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium. Experimental Parasitology. 125: 315-24. PMID 20219464 DOI: 10.1016/j.exppara.2010.02.009  0.48
2010 Camateros P, Marino R, Fortin A, Martin JG, Skamene E, Sladek R, Radzioch D. Identification of novel chromosomal regions associated with airway hyperresponsiveness in recombinant congenic strains of mice. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 21: 28-38. PMID 20012967 DOI: 10.1007/s00335-009-9236-z  0.48
2010 Meunier C, Cai J, Fortin A, Kwan T, Marquis JF, Turbide C, Van Der Kraak L, Jothy S, Beauchemin N, Gros P. Characterization of a major colon cancer susceptibility locus (Ccs3) on mouse chromosome 3 Oncogene. 29: 647-661. PMID 19915610 DOI: 10.1038/onc.2009.369  0.48
2010 Kong XF, Vogt G, Chapgier A, Lamaze C, Bustamante J, Prando C, Fortin A, Puel A, Feinberg J, Zhang XX, Gonnord P, Pihkala-Saarinen UM, Arola M, Moilanen P, Abel L, et al. A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon. Human Molecular Genetics. 19: 434-44. PMID 19880857 DOI: 10.1093/hmg/ddp507  0.48
2008 Thifault S, Ondrej S, Sun Y, Fortin A, Skamene E, Lalonde R, Tremblay J, Hamet P. Genetic determinants of emotionality and stress response in AcB/BcA recombinant congenic mice and in silico evidence of convergence with cardiovascular candidate genes. Human Molecular Genetics. 17: 331-44. PMID 17913702 DOI: 10.1093/hmg/ddm277  0.48
2007 Min-Oo G, Stevenson MM, Fortin A, Gros P. Genetic control of host-pathogen interactions in mice. Novartis Foundation Symposium. 281: 156-65; discussion 1. PMID 17534072  0.48
2007 Fortin A, Diez E, Henderson JE, Mogil JS, Gros P, Skamene E. The AcB/BcA recombinant congenic strains of mice: strategies for phenotype dissection, mapping and cloning of quantitative trait genes. Novartis Foundation Symposium. 281: 141-53; discussion 1. PMID 17534071  0.48
2007 Fortin A, Abel L, Casanova JL, Gros P. Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis. Annual Review of Genomics and Human Genetics. 8: 163-92. PMID 17492906 DOI: 10.1146/annurev.genom.8.080706.092315  0.84
2007 Min-Oo G, Fortin A, Pitari G, Tam M, Stevenson MM, Gros P. Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus. The Journal of Experimental Medicine. 204: 511-24. PMID 17312006 DOI: 10.1084/jem.20061252  0.48
2004 Apuzzo S, Abdelhakim A, Fortin AS, Gros P. Cross-talk between the paired domain and the homeodomain of Pax3: DNA binding by each domain causes a structural change in the other domain, supporting interdependence for DNA Binding. The Journal of Biological Chemistry. 279: 33601-12. PMID 15148315 DOI: 10.1074/jbc.M402949200  0.84
2004 Min-Oo G, Fortin A, Tam MF, Gros P, Stevenson MM. Phenotypic expression of pyruvate kinase deficiency and protection against malaria in a mouse model. Genes and Immunity. 5: 168-75. PMID 15029238 DOI: 10.1038/sj.gene.6364069  0.48
2003 Min-Oo G, Fortin A, Tam MF, Nantel A, Stevenson MM, Gros P. Pyruvate kinase deficiency in mice protects against malaria. Nature Genetics. 35: 357-62. PMID 14595440 DOI: 10.1038/ng1260  0.48
2002 Su Z, Fortin A, Gros P, Stevenson MM. Opsonin-independent phagocytosis: an effector mechanism against acute blood-stage Plasmodium chabaudi AS infection. The Journal of Infectious Diseases. 186: 1321-9. PMID 12402202 DOI: 10.1086/344576  0.48
2002 Fortin A, Stevenson MM, Gros P. Susceptibility to malaria as a complex trait: big pressure from a tiny creature. Human Molecular Genetics. 11: 2469-78. PMID 12351583  0.48
2002 Fortin A, Stevenson MM, Gros P. Complex genetic control of susceptibility to malaria in mice. Genes and Immunity. 3: 177-86. PMID 12058252 DOI: 10.1038/sj.gene.6363841  0.48
2001 Fortin A, Cardon LR, Tam M, Skamene E, Stevenson MM, Gros P. Identification of a new malaria susceptibility locus (Char4) in recombinant congenic strains of mice. Proceedings of the National Academy of Sciences of the United States of America. 98: 10793-8. PMID 11535821 DOI: 10.1073/pnas.191288998  0.48
2001 Fortin A, Diez E, Rochefort D, Laroche L, Malo D, Rouleau GA, Gros P, Skamene E. Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics. 74: 21-35. PMID 11374899 DOI: 10.1006/geno.2001.6528  0.48
2000 Mitsos LM, Cardon LR, Fortin A, Ryan L, LaCourse R, North RJ, Gros P. Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice. Genes and Immunity. 1: 467-77. PMID 11197687 DOI: 10.1038/sj.gene.6363712  0.84
2000 Fortin A, Penman M, Stevenson MM, Krieger M, Gros P. Identification and characterization of naturally occurring variants of the macrophage scavenger receptor (SR-A). Mammalian Genome : Official Journal of the International Mammalian Genome Society. 11: 779-85. PMID 10967138 DOI: 10.1007/s003350010131  0.48
1998 Fortin AS, Underhill DA, Gros P. Helix 2 of the paired domain plays a key role in the regulation of DNA-binding by the Pax-3 homeodomain. Nucleic Acids Research. 26: 4574-81. PMID 9753723 DOI: 10.1093/nar/26.20.4574  0.84
1997 Fortin A, Belouchi A, Tam MF, Cardon L, Skamene E, Stevenson MM, Gros P. Genetic control of blood parasitaemia in mouse malaria maps to chromosome 8. Nature Genetics. 17: 382-3. PMID 9398835 DOI: 10.1038/ng1297-382  0.48
1997 Fortin AS, Underhill DA, Gros P. Reciprocal effect of Waardenburg syndrome mutations on DNA binding by the Pax-3 paired domain and homeodomain. Human Molecular Genetics. 6: 1781-90. PMID 9302254 DOI: 10.1093/hmg/6.11.1781  0.84
Show low-probability matches.